Breaking News

Threats prompt hospitals to strip websites of info on gender-affirming care; ancient DNA research wins medicine Nobel

 

 

Daily Recap

Harassment prompts children's hospitals to strip websites, threatening access to gender-affirming care

By Tara Bannow and Kate Sheridan

Adobe

Children's hospitals, facing harassment online, are stripping their websites of information about gender-affirming care.

Read More

Nobel Prize in medicine awarded for research into the evolutionary history of humankind

By Megan Molteni

Christian Charisius/dpa via AP

Svante Pääbo accomplished something widely believed to be impossible: recovering and reading DNA from 40,000-year-old bones.

Read More

STAT+: Epic overhauls popular sepsis algorithm criticized for faulty alarms

By Casey Ross

Adobe

Epic Systems has revamped its widely criticized sepsis prediction model in a bid to improve its accuracy and make its alerts more meaningful.

Read More

White House's open-access research directive scrambles long-entrenched models, raising key questions

By Brittany Trang

Adobe

The Biden administration's embrace of open access raises key issues not only for scholarly publishing but also for science itself.

Read More

To prevent unnecessary biopsies, scientists train an AI model to predict breast cancer risk from MRI scans

By Jayne Williamson-Lee

Adobe

Researchers are testing AI as a way to better predict when biopsies for suspected breast cancer are needed.

Read More

Opinion: How can the latest Alzheimer's therapy reach patients? Follow this trustworthy process

By Jason Karlawish

Adobe

Top-line results for treating Alzheimer's with lecanemab look promising, but there are lessons to be learned from the failure of Aduhelm.

Read More

Opinion: Will there be a Supreme assault on public health?

By Michelle A. Williams and Lawrence O. Gostin

Drew Angerer/Getty Images

In just seven days last June, the U.S. Supreme Court set back public health by 50 years. It could do the same, or worse, this term.

Read More

STAT+: Many trials to confirm benefits of drugs granted accelerated approvals are running late

By Ed Silverman

Adobe

Delays can result in drugs staying on the market for years without the predicted clinical benefit being verified, the report concluded.

Read More

Monday, October 3, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments